Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 41.00
High: 41.00
Low: 39.20
Prev. Close: 41.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Anexo revenue up; Maintel hails "confident start" to 2024

Wed, 01st May 2024 13:14

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Anexo Group PLC - Liverpool, England-based integrated credit hire and legal services company - Revenue in 2023 rises 8.0% to GBP149.3 million from GBP138.3 million in 2022. Pretax profit falls 3.7% to GBP23.0 million from GBP23.9 million, however. "This reflects the investment in staff and marketing costs noted above as well as a general increase in finance costs as interest rates impacted the cost of capital to the group," Anexo adds. Net finance costs amount to GBP16.7 million, up markedly from GBP6.3 million.

----------

Maintel Holdings PLC - London-based cloud and managed communications service provider - Revenue in 2023 grows 11% to GBP101.3 million from GBP91.0 million. Pretax loss, however, widens to GBP6.8 million from GBP4.9 million. Maintel says: "The significant increase in revenue year on year reflects accelerated trading momentum in the second half, which delivered growth beyond the successful delivery of the order book contracted in 2022." Hurting profit, it reports GBP5.1 million worth of transformation costs, against none in 2022, and GBP1.5 million in staff restructuring and other employee related costs, up from GBP417,000. Maintel says: "Having concluded our organisational and strategic transformation in 2023, positioning the business to generate strong growth and deliver solid economic performance in the years to come, Maintel is focus remains on margin improvement, mitigating the impact of continued inbound price pressure, and on opportunities in high growth segments in 2024." It hails a "confident start" to 2024.

----------

Concurrent Technologies PLC - designer and manufacturer of computer products - Revenue in 2023 rises 73% to GBP31.7 million from GBP18.3 million in 2022. Pretax profit surges to GBP3.5 million from GBP382,681. CEO Miles Adcock comments: "We achieved remarkable success in FY23, putting in place the building blocks that will enable us to deliver long-term, sustainable growth. This is driven by significant design-in wins and strategic investment in the Systems division, including the acquisition of Phillips Aerospace." It proposes a 1.0p per share dividend, after not paying one for 2022.

----------

Dianomi PLC - London-based digital advertising platform - Revenue in 2023 falls 16% to GBP30.2 million from GBP35.9 million. Dianomi swings to a pretax loss of GBP1.8 million, from profit of GBP1.1 million. It puts the weaker revenue to "lower traffic levels across the publisher base and a lower level of revenue being generated from new publishers coming on to the platform during the year compared to previous years". Looking to 2024, it says elections in the US and a "further 63 countries around the world" are likely to lift traffic across its publisher base. Trading so far in 2024 is "in line with management expectations".

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company developing and marketing digital brain health assessment solutions - Revenue in 2023 rises 7.2% to GBP13.5 million from GBP12.6 million. Pretax loss stretches to GBP3.5 million from GBP624,000, however. Total operating expense increases 43% to GBP14.4 million from GBP10.1 million. Looking ahead, it says: "The company's pipeline of opportunities for the remainder of 2024 is healthy. The first quarter has already seen an increase in contract wins compared to the same period last year, however, with several major contract delays, the majority of new business is expected to occur in the second half of 2024." Depending on the timing of contract wins, it expects 2024 revenue in range of GBP13.0 million to GBP15.0 million. The firm says Chief Financial Officer Stephen Symonds will step down by end of September to join "an unrelated business". "Stephen has made an important contribution to the leadership and development of the Company and will continue as CFO to support a smooth handover while a successor is recruited," the firm says. Symonds joined as CFO in April 2022.

----------

Intelligent Ultrasound Group PLC - Cardiff, Wales-based provider of artificial intelligence ultrasound software - Revenue in 2023 rises to GBP11.2 million, from GBP10.1 million in 2022. Revenue in 2022 had included one-off GBP1.9 million simulation orders from UK NHS. Without this, revenue grows 36% in 2023, it adds. Pretax loss slims to GBP3.0 million from GBP3.7 million. Looking ahead, Intelligent Ultrasound says: "The UK market is experiencing tougher trading conditions due to the current reduction in NHS capital expenditure spending but anticipate growing revenue from high margin AI-related products and non-UK related simulation markets." It expects 2024 revenue between GBP14 million and GBP17 million "and continues to forecast that it will reach profitability with its current cash resources".

----------

Georgia Capital PLC - Tbilisi-based investor in domestic businesses in Georgia - Net asset value per share at March 31 first-quarter end rises 8.6% to GEL90.04, from GEL82.94 in December. In sterling terms, NAV per share improves 9.3% to GBP26.48 from GBP24.23. Net income during period jumps to GEL287.6 million, around GBP85.9 million, from GEL80.6 million. "Our robust balance sheet and capital allocation management, coupled with the strong performance of our portfolio companies, led to outstanding results in 1Q24," it says. "Looking ahead, with the expected rebound in the operating performance of our hospitals and retail (pharmacy) businesses in 2H24, we anticipate an even more significant opportunity for value creation across our portfolio companies."

----------

Aterian PLC - investment company focused on African mineral resources - Pretax loss in 2023 narrows to GBP1.1 million from GBP4.4 million in 2022. Reports no revenue, unchanged from prior year. Administrative expenses up 48% to GBP1.5 million from GBP996,000 in 2022. However, it reports no provisions for impairment charges, versus GBP3.0 million in 2022. Aterian says: "We believe the outlook for Aterian remains very positive. We remain confident that our existing asset portfolio has the potential to deliver tremendous value to the Company, its shareholders and other stakeholders, as demonstrated in large part by our recent announcement of our joint venture with Rio Tinto for lithium exploration in Rwanda. We will continue to update shareholders as we deliver on our value-creation plans with the results of our ongoing exploration and corporate activities."

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
31 Jan 2019 13:28

Cambridge Cognition soars on Indian software partnership

(Sharecast News) - Cambridge Cognition leapt on Thursday after entering a partnership with a major pharmaceutical company to deliver online neurological testing to patients in India using its cloud-based CANTAB Connect platform.

Read more
19 Dec 2018 08:52

Cambridge Cognition shares tumble as revenues fall short of expectations

(Sharecast News) - Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.

Read more
20 Sep 2018 12:35

Cambridge Cognition Holdings Loss Widens As Revenue Drops

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that its loss for the first half of the financial year widened as it recorded a drop in revenue as a result of the new IFRS

Read more
19 Sep 2018 12:45

Cambridge Cognition To Provide NeuroVocalix For Virtual Clinical Tests

LONDON (Alliance News) - Cambridge Cognition Holdings PLC on Wednesday said it signed its first commercial contract with an undisclosed pharmaceutical firm for its recently launched NeuroVocalix a

Read more
19 Sep 2018 10:14

Cambridge Cognition announces first NeuroVocalix commercial partnership

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced its first commercial partnership for its recently launched 'NeuroVocalix' voice biomarker technology on Wednesday.

Read more
13 Sep 2018 11:14

Cambridge Cognition's NeuroVocalix Set For Clinical Trial Use

LONDON (Alliance News) - Neuroscience technology firm Cambridge Cognition Holdings PLC on Thursday said its NeuroVocalix platform is ready for clinical trials.NeuroVocalix, the company to a

Read more
1 Aug 2018 11:51

Cambridge Cognition Inks US Production Distribution For CANTAB

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that it signed a commercial collaboration with health provider Healthy Amplified to launch its software product to better a

Read more
17 May 2018 16:01

UK Shareholder Meetings Calendar - Next 7 Days

Friday 18 MayPaddy Power BetfairIndependent News & (T)PetrofacJohn Group (re by

Read more
22 Mar 2018 13:03

Cambridge Cognition Shares Fall As It Swings To Annual Loss

LONDON (Alliance News) - Shares fell in Cambridge Cognition Holdings PLC on Thursday as it swung to a loss in 2017 from a maiden profit due to higher costs and lower in the at

Read more
14 Mar 2018 12:47

Oil majors give in to investors with share buyback spree

By Nivedita Bhattacharjee March 14 (Reuters) - After almost three barren years for investors who have poured millions into the U.S. oil sector, producers are finally to

Read more
25 Jan 2017 08:27

Cambridge Cognition gains US regulatory approval for memory test

(ShareCast News) - Neuroscience digital health company Cambridge Cognition has gained regulatory clearance for its memory test to be used as a medical device in the US. Cantab Mobile, which detects clinically-relevant memory impairment in older adults at the point of care, received 510k clearance fo

Read more
13 Oct 2016 10:55

Cambridge Cognition confirms series of new contracts

(ShareCast News) - Neuroscience company Cambridge Cognition Holdings announced a series of new contracts worth more than £0.25m on Thursday, to assess - through CANTAB Connect - the abuse potential of investigational drugs in a new market application for the company. The AIM-traded firm claimed that

Read more
22 Sep 2016 10:23

Cambridge Cognition's sales up after investments in marketing

(ShareCast News) - Cambridge Cognition' half-year revenues grew and losses were more than halved as the neuroscience software and hardware company's invested in marketing and development. For the six months ended 30 June, revenue increased by 11.3% to £3.26, compared to the same period last year. T

Read more
22 Sep 2016 08:51

Cambridge Cognition Loss Narrows On Strong Revenue Growth

Read more
20 Sep 2016 08:07

Cambridge Cognition Inks First Contract For CANTAB Recruit Product

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.